SOYLENT GREEN: BIG PHARMA GIANT GLAXOSMITHKLINE SPENDS $300 MILLION FOR ACCESS TO DNA DATABASE OF GENEALOGY TRACKING COMPANY 23ANDME

This post was originally published on this site

by Geoffrey Grinder, Now The End Begins: Customers were still surprised and angry, unaware of what they had already signed (and spat) away. GSK will receive the same kind of data pharma partners have generally received—summary level statistics that 23andMe scientists gather from analyses on de-identified, aggregate customer information—though it will have four years of […]

The post SOYLENT GREEN: BIG PHARMA GIANT GLAXOSMITHKLINE SPENDS $300 MILLION FOR ACCESS TO DNA DATABASE OF GENEALOGY TRACKING COMPANY 23ANDME appeared first on SGT Report.

Print Friendly, PDF & Email

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.